SEZEN KARAOĞLAN, E. Et Al. 2018. Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells. Current Pharmaceutical Analysis , vol.14 , 578-585.

SEZEN KARAOĞLAN, E., GÜNDOĞDU, G., SEÇME, M., ŞENOL, O., DEMİRKAYA MİLOĞLU, F., DODURGA, Y., ... TÜFEKÇİ, A. R.(2018). Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells. Current Pharmaceutical Analysis , vol.14, 578-585.

SEZEN KARAOĞLAN, Esen Et Al. "Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells," Current Pharmaceutical Analysis , vol.14, 578-585, 2018

SEZEN KARAOĞLAN, Esen S. Et Al. "Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells." Current Pharmaceutical Analysis , vol.14, pp.578-585, 2018

SEZEN KARAOĞLAN, E. Et Al. (2018) . "Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells." Current Pharmaceutical Analysis , vol.14, pp.578-585.

@article{article, author={Esen SEZEN KARAOĞLAN Et Al. }, title={Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells}, journal={Current Pharmaceutical Analysis}, year=2018, pages={578-585} }